Advanced triple-agonist peptide (GLP-1, GIP, Glucagon) for cutting-edge metabolic research. Enhanced efficacy for weight management and energy expenditure studies.
Triple Agonist
Fat Loss
Metabolism
Secure checkout via Stripe • For research purposes only
Retatrutide is an advanced peptide research compound designed for metabolic studies. As a triple agonist targeting GLP-1, GIP, and Glucagon receptors, it represents the next generation of metabolic research peptides.
This peptide is supplied at the highest purity standards for laboratory and research applications only. Not intended for human consumption or therapeutic use.
Research on appetite regulation, energy expenditure, and metabolic optimization.
Investigation of GLP-1, GIP, and Glucagon receptor mechanisms.
Research on thermogenesis and fat oxidation processes.
Studies on glucose metabolism and insulin sensitivity.
Important: This product is for research and laboratory use only. Not for human consumption or therapeutic applications. Proper laboratory safety protocols must be followed.